Skip to main content

Find Clinical Trials

Home
Conditions
Neurofibroma

Clinical trial condition

Neurofibroma

Explore clinical trials studying Neurofibroma. Study availability and eligibility vary by location and protocol.

235 public trials 39 recruiting studies

Refine in advanced search Browse all conditions

Neurofibroma trial results

Completed

Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

NCT00474994

Conditions: AIDS-related Kaposi sarcoma, Adnexal Diseases, Adult Malignant Fibrous Histiocytoma of Bone, +75 more
Locations: Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Sorafenib and Dacarbazine in Soft Tissue Sarcoma

NCT00837148

Conditions: Fibrosarcoma, Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, +18 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Reliability of Functional Outcome Measures in Neurofibromatosis 1

NCT02479360

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations: Neurofibromatosis Unit, Guys Hospital. London, United Kingdom

View Trial Details

Completed

Functional Imaging and Reading Deficit in Children With NF1

NCT02422732

Conditions: Communication Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslexia, +25 more
Locations: CHU Toulouse Toulouse, France

View Trial Details

Completed

Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas

NCT00053937

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +19 more
Locations: University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

Children's Memorial Hospital - Chicago Chicago, Illinois, United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View all 15 locations

View Trial Details

Completed

Reading Disability in Children With NF1

NCT02397967

Conditions: Communication Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslexia, +25 more
Locations: Hopital femme-mére-enfant, Hospices civils de lyon Lyon, France

Hôpital Gui de Chauliac Montpellier, France

CHU Hôtel-Dieu, Clinic of Dermatology Nantes, France

AP-HP Hopital Armand Trousseau Paris, France

View Trial Details

Completed

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2

NCT00004437

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +37 more
Locations: Not specified

View Trial Details

Completed

An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors

NCT00030043

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +24 more
Locations: House Ear Institute Los Angeles, California, United States

Huntington Medical Research Institutes Pasadena, California, United States

Cochlear Corporation Englewood, Colorado, United States

View Trial Details

Completed

Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas

NCT01412892

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +18 more
Locations: Henri Mondor Hospital Créteil, France

View Trial Details

Completed

Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

NCT00061984

Conditions: Fibrosarcoma, Hemangiosarcoma, Histiocytoma, +24 more
Locations: Karl-Franzens-University Graz Graz, Austria

Institut Jules Bordet Brussels, Belgium

Universitair Ziekenhuis Antwerpen Edegem, Belgium

U.Z. Gasthuisberg Leuven, Belgium

View all 41 locations

View Trial Details